Earnings Call · Q2 FY2025·2025-07-30

Q2 25EPS +100.00%*·Rev n/aQ1 25EPS +10.68%·Rev n/aQ4 24EPS +49.03%·Rev n/aQ3 24EPS +18.10%·Rev n/a⚠ consensus missing

IONIS PHARMACEUTICALS INC IONS

D. Wade Walke — Senior Vice President, Investor Relations

Brett P. Monia — Chief Executive Officer

Kyle Jenne — Senior Vice President, Commercial

Richard S. Geary — Chief Operating Officer

Elizabeth L. Hougen — Chief Financial Officer

+4.6%1d on move date+4.7% vs SPY3d+3.7%5d+3.8%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IONS calls or request research access.

More IONS calls Browse calls Request research access